XML 46 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Revisions of Previously Issued Financial Statements (Tables)
3 Months Ended 12 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Schedule of financial statements
  Three Months Ended September 30, 2019 
   As reported   Adjustment   As revised 
Condensed Consolidated Statements of Operations            
Cost of revenue  $1,397,361   $(17,660)  $1,379,701 
Gross profit   1,795,529    17,660    1,813,189 
Product development   1,130,880    (519,978)   610,902 
Selling, general and administrative   3,583,815    17,899    3,601,714 
Net loss   (2,846,071)   519,739    (2,326,332)
Net loss per share   (0.26)       (0.21)
                
   Three Months Ended December 31, 2019 
   As reported   Adjustment   As revised 
Condensed Consolidated Statements of Operations            
Cost of revenue  $1,638,840   $(23,601)  $1,615,239 
Gross profit   1,667,363    23,601    1,690,964 
Product development   1,261,509    (638,008)   623,501 
Selling, general and administrative   4,796,404    86,768    4,883,172 
Net loss   (4,338,536)   574,841    (3,763,695)
Net loss per share   (0.40)       (0.34)
                
   Six Months Ended December 31, 2019 
   As reported   Adjustment   As revised 
Condensed Consolidated Statements of Operations            
Cost of revenue  $3,036,201   $(41,261)  $2,994,940 
Gross profit   3,462,892    41,261    3,504,153 
Product development   2,392,389    (1,157,986)   1,234,403 
Selling, general and administrative   8,380,219    104,667    8,484,886 
Net loss   (7,184,607)   1,094,580    (6,090,027)
Net loss per share   (0.66)       (0.56)
                
   Three Months Ended March 31, 2020 
   As reported   Adjustment   As revised 
Condensed Consolidated Statement of Operations            
Cost of revenue  $1,420,909   $(24,690)  $1,396,219 
Gross profit   1,649,637    24,690    1,674,327 
Product development   1,632,353    (757,566)   874,787 
Selling, general and administrative   5,500,837    177,405    5,678,242 
Net loss   (5,348,980)   604,851    (4,744,129)
Net loss per share   (0.43)       (0.38)
                
   Nine Months Ended March 31, 2020 
   As reported   Adjustment   As revised 
Condensed Consolidated Statements of Operations            
Cost of revenue  $4,457,110   $(65,951)  $4,391,159 
Gross profit   5,112,529    65,951    5,178,480 
Product development   4,024,742    (1,915,552)   2,109,190 
Selling, general and administrative   13,881,056    282,072    14,163,128 
Net loss   (12,533,587)   1,699,431    (10,834,156)
Net loss per share   (1.11)       (0.96)

   Three Months Ended
September 30, 2019
 
   As reported   Adjustment   As revised 
Condensed Consolidated Statements of Operations            
Cost of revenue  $1,397,361   $(17,660)  $1,379,701 
Gross profit   1,795,529    17,660    1,813,189 
Product development   1,130,880    (519,978)   610,902 
Selling, general and administrative   3,583,815    17,899    3,601,714 
Net loss   (2,846,071)   519,739    (2,326,332)
Net loss per share   (0.26)        (0.21)

 

   Three Months Ended
December 31, 2019
 
   As reported   Adjustment   As revised 
Condensed Consolidated Statements of Operations            
Cost of revenue   1,638,840    (23,601)   1,615,239 
Gross profit   1,667,363    23,601    1,690,964 
Product development   1,261,509    (638,008)   623,501 
Selling, general and administrative   4,796,404    86,768    4,883,172 
Net loss   (4,338,536)   574,841    (3,763,695)
Net loss per share   (0.40)        (0.34)

 

    Six Months Ended
December 31, 2019
 
    As reported   Adjustment   As revised  
Condensed Consolidated Statements of Operations                    
Cost of revenue     3,036,201     (41,261)     2,994,940  
Gross profit     3,462,892     41,261     3,504,153  
Product development     2,392,389     (1,157,986)     1,234,403  
Selling, general and administrative     8,380,219     104,667     8,484,886  
Net loss     (7,184,607 )   1,094,580     (6,090,027 )
Net loss per share     (0.66 )         (0.56 )

 

   Three Months Ended
March 31, 2020
 
   As reported   Adjustment   As revised 
Condensed Consolidated Statement of Operations            
Cost of revenue   1,420,909    (24,690)   1,396,219 
Gross profit   1,649,637    24,690    1,674,327 
Product development   1,632,353    (757,566)   874,787 
Selling, general and administrative   5,500,837    177,405    5,678,242 
Net loss   (5,348,980)   604,851    (4,744,129)
Net loss per share   (0.43)        (0.38)

 

   Nine Months Ended
March 31, 2020
 
   As reported   Adjustment   As revised 
Condensed Consolidated Statements of Operations            
Cost of revenue   4,457,110    (65,951)   4,391,159 
Gross profit   5,112,529    65,951    5,178,480 
Product development   4,024,742    (1,915,552)   2,109,190 
Selling, general and administrative   13,881,056    282,072    14,163,128 
Net loss   (12,533,587)   1,699,431    (10,834,156)
Net loss per share   (1.11)        (0.96)